GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Steep Hill Inc (XCNQ:STPH) » Definitions » Debt-to-EBITDA

Steep Hill (XCNQ:STPH) Debt-to-EBITDA : -0.43 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Steep Hill Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Steep Hill's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.02 Mil. Steep Hill's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.00 Mil. Steep Hill's annualized EBITDA for the quarter that ended in Dec. 2023 was C$-0.04 Mil. Steep Hill's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.43.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Steep Hill's Debt-to-EBITDA or its related term are showing as below:

XCNQ:STPH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.23   Med: -0.11   Max: -0.02
Current: -0.04

During the past 5 years, the highest Debt-to-EBITDA Ratio of Steep Hill was -0.02. The lowest was -0.23. And the median was -0.11.

XCNQ:STPH's Debt-to-EBITDA is ranked worse than
100% of 657 companies
in the Drug Manufacturers industry
Industry Median: 1.69 vs XCNQ:STPH: -0.04

Steep Hill Debt-to-EBITDA Historical Data

The historical data trend for Steep Hill's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steep Hill Debt-to-EBITDA Chart

Steep Hill Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
- -0.23 -0.18 -0.02 -0.04

Steep Hill Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.14 -0.08 -0.27 -0.43

Competitive Comparison of Steep Hill's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Steep Hill's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Steep Hill's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Steep Hill's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Steep Hill's Debt-to-EBITDA falls into.



Steep Hill Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Steep Hill's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.019 + 0) / -0.445
=-0.04

Steep Hill's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.019 + 0) / -0.044
=-0.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Steep Hill  (XCNQ:STPH) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Steep Hill Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Steep Hill's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Steep Hill (XCNQ:STPH) Business Description

Traded in Other Exchanges
N/A
Address
120 Adelaide Street West, Suite 2500, Toronto, ON, CAN, M5H 1T1
Steep Hill Inc is a science and technology health and wellness company focused on the hemp markets inclusive of plant-based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals. Currently the company, through its subsidiaries holds three industrial hemp licences for the purposes of supplying the global market with medicinal and wellness cannabidiol and other cannabinoid-based products.

Steep Hill (XCNQ:STPH) Headlines

No Headlines